See also stories tagged with Nanoparticle
Within tumors in the human body, there are immune cells (macrophages) capable of fighting cancer, but they have been unable to perform their roles properly due to suppression by the tumor. A KAIST research team led by Professor ...
Ammonia (NH3) is a colorless chemical compound comprised of nitrogen and hydrogen that is widely used in agriculture and in industrial settings. Among other things, it is used to produce fertilizers, as well as cleaning products ...
Filoviruses get their name from the Latin word "filum," meaning thread—a reference to their long, filamentous shape. This virus family contains some of the most dangerous pathogens known to science, including Ebola, Sudan, ...
Using proteins from a common tobacco plant virus, McGill chemistry researchers have developed a simple, eco-friendly way to arrange gold nanoparticles into ultrathin sheets, strengthening the particles' optical properties. ...
Vibrio bacteria are major pathogens in the aquaculture industry, triggering vibriosis—a disease that can cause mortality rates of up to 90% within two days. This not only results in billions of dollars in economic losses ...
In the home, the lab and the factory, electric fields control technologies such as Kindle displays, medical diagnostic tests and devices that purify cancer drugs. In an electric field, anything with an electrical charge—from ...
Japan's Innovation Center of NanoMedicine reports on a new stealth coating for tiny medicine-carrying particles that doesn't depend on PEG-style shields. By locking positive and negative charges together into a tight net, ...
A new delivery particle developed at MIT could make mRNA vaccines more effective and potentially lower the cost per vaccine dose.
Modern beer production is a US$117 billion business in the United States, with brewers producing over 170 million barrels of beer per year. The brewing process is time- and energy-intensive, and each step generates large ...
Cardiovascular disease continues to be the leading cause of death worldwide. But advances in heart-failure therapeutics have stalled, largely due to the difficulty of delivering treatments at the cellular level. Now, a UC ...
